BONEH — BBS-Bioactive Bone Substitutes Oyj Share Price
Last trade - 00:00- €9.26m
- €12.05m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.81 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -36.45% | ||
| Return on Equity | -74.28% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | n/a | n/a | n/a | n/a | n/a | n/a | 1 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BBS-Bioactive Bone Substitutes Oyj (BBS) is a Finland-based company engaged in the medical equipment industry. The Company operates as a biotechnology company that develops and distributes medical device implants used in orthopedic surgery. Its products include ARTEBONE, an orthopedic bone substitute material made from reindeer bone protein matrix made using a propriety patented manufacturing process that can be used in various application areas, such as bone regeneration, healing of fractures, non-unions, bone defect, dental implantation, orthopedics, maxillofacial/dental surgery and osteoporotic fractures.
Directors
- Jarmo Halonen CHM (66)
- Ilkka Kangasniemi CEO (58)
- Liisa Hukka CFO
- Hanna Tolli COO (35)
- Soile Hakala OTH
- Merja Haikola MGB
- Mikko Viitanen MGB (51)
- Pekka Jalovaara DRC (78)
- Auvo Kaikkonen DRC (58)
- Seppo Nevalainen DRC (66)
- Tomi Numminen DRC (51)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- February 6th, 1991
- Public Since
- February 28th, 2018
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange - Helsinki
- Shares in Issue
- 19,297,175
- Address
- Kiviharjunlenkki 6, OULU, 90220
- Web
- https://www.bbs-artebone.fi/
- Phone
- +358 207924700
- Auditors
- Ernst & Young Oy
Upcoming Events for BONEH
Similar to BONEH
Bioretec Oy
OMX Nordic Exchange - Helsinki
DETECTION TECHNOLOGY Oyj
OMX Nordic Exchange - Helsinki
Modulight Oyj
OMX Nordic Exchange - Helsinki
Nexstim Oyj
OMX Nordic Exchange - Helsinki
Nightingale Health Oyj
OMX Nordic Exchange - Helsinki
FAQ
As of Today at 19:03 UTC, shares in BBS-Bioactive Bone Substitutes Oyj are trading at €0.48. This share price information is delayed by 15 minutes.
Shares in BBS-Bioactive Bone Substitutes Oyj last closed at €0.48 and the price had moved by -35.34% over the past 365 days. In terms of relative price strength the BBS-Bioactive Bone Substitutes Oyj share price has underperformed the FTSE Global All Cap Index by -39.3% over the past year.
The overall consensus recommendation for BBS-Bioactive Bone Substitutes Oyj is Sell. You can view the full broker recommendation list by unlocking its StockReport.
BBS-Bioactive Bone Substitutes Oyj does not currently pay a dividend.
BBS-Bioactive Bone Substitutes Oyj does not currently pay a dividend.
BBS-Bioactive Bone Substitutes Oyj does not currently pay a dividend.
To buy shares in BBS-Bioactive Bone Substitutes Oyj you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €0.48, shares in BBS-Bioactive Bone Substitutes Oyj had a market capitalisation of €9.26m.
Here are the trading details for BBS-Bioactive Bone Substitutes Oyj:
- Country of listing: Finland
- Exchange: HEX
- Ticker Symbol: BONEH
Based on an overall assessment of its quality, value and momentum BBS-Bioactive Bone Substitutes Oyj is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in BBS-Bioactive Bone Substitutes Oyj is €0.50. That is 4.17% above the last closing price of €0.48.
Analysts covering BBS-Bioactive Bone Substitutes Oyj currently have a consensus Earnings Per Share (EPS) forecast of -€0.21 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BBS-Bioactive Bone Substitutes Oyj. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +1.16%.
As of the last closing price of €0.48, shares in BBS-Bioactive Bone Substitutes Oyj were trading -0.64% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The BBS-Bioactive Bone Substitutes Oyj PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.48.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
BBS-Bioactive Bone Substitutes Oyj's management team is headed by:
- Jarmo Halonen - CHM
- Ilkka Kangasniemi - CEO
- Liisa Hukka - CFO
- Hanna Tolli - COO
- Soile Hakala - OTH
- Merja Haikola - MGB
- Mikko Viitanen - MGB
- Pekka Jalovaara - DRC
- Auvo Kaikkonen - DRC
- Seppo Nevalainen - DRC
- Tomi Numminen - DRC